| ۲۱ | An insight into the potential role of LINC00968 in luminal breast cancer: Case-control study and bioinformatics analysis | Arabpour, M., Mehrpour Layeghi, S., Majidzadeh-A, K., (...), Naghizadeh, M.M., Shakoori, A. | Biochemistry and Biophysics Reports | 2023-9-1 |
| ۲۲ | A micropillar array-based microfluidic chip for label-free separation of circulating tumor cells: The best micropillar geometry? | Rahmanian, M., Sartipzadeh Hematabad, O., Askari, E., (...), den Toonder, J.M.J., Majidzadeh-A, K. | Journal of Advanced Research | 2023-5-1 |
| ۲۳ | A micropillar array-based microfluidic chip for label-free separation of circulating tumor cells: The best micropillar geometry? | Rahmanian, M., Sartipzadeh Hematabad, O., Askari, E., (...), den Toonder, J.M.J., Majidzadeh-A, K. | Journal of Advanced Research | 2023-5-1 |
| ۲۴ | Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19 | Ahmadvand, M., Barough, M.S., Hashemi, Z.S., (...), Ghavamzadeh, A., Forooshani, R.S. | Pilot and Feasibility Studies | 2023-12-1 |
| ۲۵ | The burden of prostate cancer in North Africa and Middle East, 1990-2019: Findings from the global burden of disease study | Abbasi-Kangevari, M., Moghaddam, S.S., Ghamari, S.-H., (...), Yuce, D., Zare, I. | Frontiers in Oncology, | 2022-9-13 |
| ۲۶ | The burden of prostate cancer in North Africa and Middle East, 1990-2019: Findings from the global burden of disease study | Abbasi-Kangevari, M., Moghaddam, S.S., Ghamari, S.-H., (...), Yuce, D., Zare, I. | Frontiers in Oncology, | 2022-9-13 |
| ۲۷ | Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance | Darvishi, B., Eisavand, M.R., Majidzadeh-A, K., Farahmand, L. | British Journal of Cancer, | 2022-5-18 |
| ۲۸ | Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance | Darvishi, B., Eisavand, M.R., Majidzadeh-A, K., Farahmand, L. | British Journal of Cancer, | 2022-5-18 |
| ۲۹ | Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance | Darvishi, B., Eisavand, M.R., Majidzadeh-A, K., Farahmand, L. | British Journal of Cancer, | 2022-5-18 |
| ۳۰ | Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance | Darvishi, B., Eisavand, M.R., Majidzadeh-A, K., Farahmand, L. | British Journal of Cancer, | 2022-5-18 |
| ۳۱ | Correction: Engineered hypoxia-responding Escherichia coli carrying cardiac peptide genes, suppresses tumor growth, angiogenesis and metastasis in vivo (Journal of Biological Engineering, (2021), 15, 1, (20), 10.1186/s13036-021-00269-2) | Samadi, M., Majidzadeh-A, K., Salehi, M., (...), Moradi-Kalbolandi, S., Farahmand, L. | Journal of Biological Engineering | 2022-12-1 |
| ۳۲ | Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment | Aghayan, H.R., Salimian, F., Abedini, A., (...), Ghavamzadeh, A., Sarrami-Forooshani, R. | Stem Cell Research and Therapy, | 2022-12-1 |
| ۳۳ | Recognition of functional genetic polymorphism using ESE motif definition: a conservative evolutionary approach to CYP2D6/CYP2C19 gene variants | Samadi, M., Beigi, L., Yadegari, F., (...), Eskordi, M., Farahmand, L. | Genetica, | 2022-10-1 |
| ۳۴ | Recognition of functional genetic polymorphism using ESE motif definition: a conservative evolutionary approach to CYP2D6/CYP2C19 gene variants | Samadi, M., Beigi, L., Yadegari, F., (...), Eskordi, M., Farahmand, L. | Genetica, | 2022-10-1 |
| ۳۵ | Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors | Merikhian, P., Darvishi, B., Jalili, N., (...), Rahbarizadeh, F., Farahmand, L. | Molecular Oncology, | 2022 |
| ۳۶ | A comprehensive reference for BRCA1/2 genes pathogenic variants in Iran: published, unpublished and novel | Majidzadeh-A, K., Zarinfam, S., Abdoli, N., (...), Salehi, M., Zamani, M. | Familial Cancer, | 2022 |
| ۳۷ | Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors | Merikhian, P., Darvishi, B., Jalili, N., (...), Rahbarizadeh, F., Farahmand, L. | Molecular Oncology, | 2022 |
| ۳۸ | A comprehensive reference for BRCA1/2 genes pathogenic variants in Iran: published, unpublished and novel | Majidzadeh-A, K., Zarinfam, S., Abdoli, N., (...), Salehi, M., Zamani, M. | Familial Cancer, | 2022 |
| ۳۹ | Development of a recombinant anti-VEGFR2-EPCAM bispecific antibody to improve antiangiogenic efficiency | Barzaman, K., Samadi, M., Moradi-kalbolandi, S., (...), Shekarabi, M., Farahmand, L. | Experimental Cell Research | 2021-8-15 |
| ۴۰ | Identification and management of Lynch syndrome in the Middle East and North African countries: outcome of a survey in 12 countries | Sina, M., Ghorbanoghli, Z., Abedrabbo, A., (...), Georgiou, D., Vasen, H.F.A. | Familial Cancer | 2021-7-1 |